Saturday , October 23 2021
Home / Tag Archives: gilead sciences (page 2)

Tag Archives: gilead sciences

Inovio (INO) Stock Crashes Over 30%, Citron Research Casts Doubt on Coronavirus Vaccine

Inovio (INO) stock has now erased some of its YTD gains after Citron Research suggested the company was grandstanding. Citron’s analysts now put INO at $2.Several factors affect the volatility of financial markets all over the world. In recent times, it’s been the coronavirus outbreak. The uncertainty and fear have caused a general plunge in the markets. However, some stocks – specifically biotech companies – rode on the epidemic for a time, and increased in value. Inovio Pharmaceuticals Inc...

Read More »

New Evergreen Stocks Such as GILD, MRNA Could Emerge amid Coronavirus

Some new evergreen stocks could become a new choice for investors. Moderna (MRNA), Gilead Sciences (GILD) and Co-Diagnostics (CODX) are also expected to change the game for coronavirus.New evergreen stocks could emerge as a result of the coronavirus crisis. These stocks have won such a status as global markets have tanked following the outbreak of COVID-19. The gaps created by coronavirus has caused the global economy to come to a standstill. This has affected the businesses all over the...

Read More »

Moderna (MRNA) Stock 3.6% Down in Premarket, CEO Says Coronavirus Vaccine to Be Affordable

Moderna (MRNA) stock has fallen since the last week’s announcement of a possible vaccine for COVID-19. Its CEO has indicated that the prices for the coronavirus vaccine will be affordable.Moderna Inc (NASDAQ: MRNA) stock remained low. It lost 1.5% yesterday and today in the premarket it is nearly 4% down. This comes as the CEO of the biotech startup has indicated that the company’s COVID-19 vaccine will be affordable. Sources report that Stephane Bancel said that the price will be within the...

Read More »

Coronavirus Could Be a Positive Game-Changer for These 5 Stocks

While many stocks are taking a big hit because of the coronavirus, the following 5 are some that are set up to benefit from the outbreak. Let’s have a look at them.The coronavirus outbreak is still driving a deep wedge into the world’s financial markets and stocks. As the situation continues to worsen, some of the world’s biggest companies are shedding significant weight in stocks as a result of the market disruptions from the coronavirus. In addition to that, the world’s richest people are...

Read More »

Coronavirus Vaccine: 5 BioTech Stocks to Buy as a Hedge against COVID-19 Threat

As major biotech companies try to create a proper coronavirus vaccine, the following stocks just might be strong enough to hedge against the current financial plunge.The coronavirus epidemic isn’t letting down as many people hope it would. Instead, the number of confirmed cases as well as the mortality rate, are on a steady rise. The number of countries affected by the virus is also increasing steadily with many more countries confirming new cases of infection. The situation is worrisome to...

Read More »

Biotech Stock Market Is Under Coronavirus Effect as Companies Are Working on Vaccine

As most stock markets continue bleeding out due to the coronavirus outbreak, three biotech stocks have been defying the urge as the companies are working on a vaccine or a cure for the deadly coronavirus.Three major biotech companies, which are working on developing a vaccine or cure for the deadly coronavirus, have seen their stock markets defy the overall market plunge. The select biotech companies have either announced testing the vaccine on human victims or in the process of verifying a...

Read More »

Gilead Sciences (GILD) Stock Surges after Launching Phase 3 Studies for Coronavirus Treatment

Gilead Sciences (GILD) stock surged and reached an all-time high after the company confirmed the launching of phase 3 studies of coronavirus treatment.Gilead Sciences Inc (NASDAQ: GILD), an American biotech company that specializes in researching, developing and commercializing drugs, has seen its stock surge after it announced the launching of phase 3 studies for naval coronavirus (COVID-19) treatment. The stock price broke a very critical resistant level at $68 to trade above $70.Amid the...

Read More »

Coronavirus Stocks: Why Gilead Sciences, Moderna, Inovio Pharmaceuticals, Novavax Rose

While tech shares are suffering drops, coronavirus stocks are soaring, The pharma companies are actively working on the development of a new vaccine.Lately, we have been reporting a lot about tech companies suffering significant drops in stocks amid spreading coronavirus concerns. Its high time to have a look at those market players who are benefiting in the volatile conditions. Under the circumstances given, the only winners are so-called coronavirus stocks. Haven stocks and health care...

Read More »

China Approves Favipiravir as Potent Treatment against New Coronavirus COVID-19 Strain

Favipiravir has become one of the drugs that the Chinese authorities approved for treating the new COVID-19 strain of the coronavirus.According to a Reuters report, China’s National Health Commission is optimistic about a resolution for the raging coronavirus. The report says that a spokesman for the Commission Mi Feng said that efforts from the authorities are yielding results. The Commission also says that at least 1,425 infected patients have been cured and discharged. As part of these...

Read More »